Fumihiro Sanada
10PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 17, 2024
A Role for Periostin Pathological Variants and Their Interaction with HSP70-1a in Promoting Pancreatic Cancer Progression and Chemoresistance.Yasuo Tsunetoshi, Fumihiro Sanada, Yuko Kanemoto
|Sep 28, 2024
Expression of Periostin Alternative Splicing Variants in Normal Tissue and Breast Cancer.Yuko Kanemoto, Fumihiro Sanada, Kana Shibata
|Sep 14, 2024
The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and Cancer.Kana Shibata, Nobutaka Koibuchi, Fumihiro Sanada
|Aug 28, 2024
Experimental Study: The Development of a Novel Treatment for Chemotherapy-Resistant Tongue Cancer with the Inhibition of the Pathological Periostin Splicing Variant 1-2 with Exon 21.Shoji Ikebe, Nobutaka Koibuchi, Kana Shibata
|Nov 11, 2022
Blocking Periostin Prevented Development of Inflammation in Rhabdomyolysis-Induced Acute Kidney Injury Mice Model.Jun Muratsu, Fumihiro Sanada, Nobutaka Koibuchi
|Oct 23, 2021
Periostin Exon-21 Antibody Neutralization of Triple-Negative Breast Cancer Cell-Derived Periostin Regulates Tumor-Associated Macrophage Polarization and Angiogenesis.Tatsuya Fujikawa, Fumihiro Sanada, Yoshiaki Taniyama
Pageof 2
